BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 16265340)

  • 1. C-reactive protein comes of age.
    Verma S; Szmitko PE; Ridker PM
    Nat Clin Pract Cardiovasc Med; 2005 Jan; 2(1):29-36; quiz 58. PubMed ID: 16265340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The novel role of C-reactive protein in cardiovascular disease: risk marker or pathogen.
    Wilson AM; Ryan MC; Boyle AJ
    Int J Cardiol; 2006 Jan; 106(3):291-7. PubMed ID: 16337036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [C-reactive protein in cardiovascular risk evaluation].
    Fabijanić D; Banić M; Kardum D
    Lijec Vjesn; 2006; 128(5-6):167-74. PubMed ID: 16910418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting risk and treatment benefit in atherosclerosis: the role of C-reactive protein.
    Koenig W
    Int J Cardiol; 2005 Feb; 98(2):199-206. PubMed ID: 15686768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on high-sensitivity C-reactive protein levels.
    Field KM
    Pharmacotherapy; 2005 Oct; 25(10):1365-77. PubMed ID: 16185181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein: a nontraditional serum marker of cardiovascular risk.
    de Ferranti SD; Rifai N
    Cardiovasc Pathol; 2007; 16(1):14-21. PubMed ID: 17218210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inflammation and C-reactive protein in cardiovascular disease].
    Munk PS; Larsen AI
    Tidsskr Nor Laegeforen; 2009 Jun; 129(12):1221-4. PubMed ID: 19521445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease.
    Nozaki T; Sugiyama S; Koga H; Sugamura K; Ohba K; Matsuzawa Y; Sumida H; Matsui K; Jinnouchi H; Ogawa H
    J Am Coll Cardiol; 2009 Aug; 54(7):601-8. PubMed ID: 19660689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein: a new golden marker of cardiovascular risk.
    Gomes MC
    Rev Port Cardiol; 2002 Nov; 21(11):1329-46. PubMed ID: 12564084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [C-reactive protein potential risk factor for cardiovascular disease].
    Tornvall P; Pernow J; Hansson LO
    Lakartidningen; 2003 Aug; 100(35):2691-3. PubMed ID: 14531129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of C-reactive protein for heart disease in dialysis patients.
    Wang AY
    Curr Opin Investig Drugs; 2005 Sep; 6(9):879-86. PubMed ID: 16187687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory biomarkers and cardiovascular risk: association or cause and effect?
    Rao M; Jaber BL; Balakrishnan VS
    Semin Dial; 2006; 19(2):129-35. PubMed ID: 16551290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
    Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [High-sensitivity C-reactive protein as a biomarker of risk in coronary artery disease].
    Silva D; Pais de Lacerda A
    Rev Port Cardiol; 2012 Nov; 31(11):733-45. PubMed ID: 23046630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemokines in cardiovascular risk prediction.
    Aukrust P; Yndestad A; Smith C; Ueland T; Gullestad L; Damås JK
    Thromb Haemost; 2007 May; 97(5):748-54. PubMed ID: 17479185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of C-reactive protein in coronary risk reduction: focus on primary prevention.
    Gotto AM
    Am J Cardiol; 2007 Mar; 99(5):718-25. PubMed ID: 17317380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [C-reactive protein and atherothrombosis--a prognostic factor or a risk factor?].
    Yosef-Levi IM; Grad E; Danenberg HD
    Harefuah; 2007 Dec; 146(12):970-4, 996. PubMed ID: 18254451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-reactive protein: a family of proteins to regulate cardiovascular function.
    Schwedler SB; Filep JG; Galle J; Wanner C; Potempa LA
    Am J Kidney Dis; 2006 Feb; 47(2):212-22. PubMed ID: 16431250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The importance of non-lipid risk factors: a review focusing on C-reactive protein].
    Yilmaz Y; Ongen Z
    Turk Kardiyol Dern Ars; 2009 Apr; 37 Suppl 4():7-13. PubMed ID: 19553756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein and atherosclerosis: quo vadis?
    Koenig W; Torzewski J
    Ital Heart J; 2001 Nov; 2(11):801-3. PubMed ID: 11770861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.